DEFINITIVE NOTICE AND PROCY STATEMENT

Company

INOVIO PHARMACEUTICALS, INC.

Filed

October 15, 2002

Period of Report

November 21, 2002

Accession Number

0000950148-02-002442

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →